Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Vyacheslav Yurievich Mareev"'
Autor:
Arintaya Phrommintikul, Oleksii Korzh, Jaromir Hradec, Thomas Muenzel, Vincent Maher, Aldo Pietro Maggioni, Olga Moiseeva, Aleksandar Neskovic, ELENA BOBESCU, WILLIAM HEDDLE, Catalina Arsenescu Georgescu, Marcelo Sanmartin-Fernandez, Yaroslav Malynovsky, Philippe Gabriel STEG, Vladimir Zadionchenko, Ben Freedman, Sergey Nedogoda, Roberto Ferrari, Vyacheslav Yurievich Mareev, Eduardo Costa Duarte Barbosa, Philippe Gosse, Andriy Bazylevych, Michal Tendera, Alfonso Varela-Román, Sergiy Kolomiets
Publikováno v:
Fox, K, Ford, I, Steg, P G, Tardif, J-C, Tendera, M, Ferrari, R & Murray, G 2014, ' Ivabradine in Stable Coronary Artery Disease without Clinical Heart Failure ', New England Journal of Medicine, vol. 371, no. 12, pp. 1091-1099 . https://doi.org/10.1056/NEJMoa1406430
New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2014, 371 (12), pp.1091-9. ⟨10.1056/NEJMoa1406430⟩
ResearcherID
New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2014, 371 (12), pp.1091-9. ⟨10.1056/NEJMoa1406430⟩
ResearcherID
BACKGROUND: An elevated heart rate is an established marker of cardiovascular risk. Previous analyses have suggested that ivabradine, a heart-rate-reducing agent, may improve outcomes in patients with stable coronary artery disease, left ventricular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a19e2fd3f6f428cf9d6c1d476f6549c
http://hdl.handle.net/11392/2336701
http://hdl.handle.net/11392/2336701
Autor:
John Alexander, Aleksandr Svistov, Job Harenberg, Mario Talajic, Maria Christiane Valeria Braga Braile-Sternieri, Ignatenko G. A., Miguel Urina, Julián Pérez-Villacastín, Sergio Leonardi, Claes Held, WILLIAM HEDDLE, Catalina Arsenescu Georgescu, Philippe Gabriel STEG, Vladimir Zadionchenko, Fernando Lanas, Vyacheslav Yurievich Mareev, Anna Bragina, Christoph Varenhorst, Philippe Gosse, Andriy Bazylevych, Holger Poppert, Sergey Golitsyn, Sergey Popov
Publikováno v:
Lancet Neurology, 11, 6, pp. 503-11
The lancet neurology
Lancet Neurology, 11, 503-11
Easton, J D, Lopes, R D, Bahit, M C, Wojdyla, D M, Granger, C B, Wallentin, L, Alings, M, Goto, S, Lewis, B S, Rosenqvist, M, Hanna, M, Mohan, P, Alexander, J H, Diener, H-C & ARISTOTLE Committees and Investigators 2012, ' Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack : a subgroup analysis of the ARISTOTLE trial ', Lancet Neurology Network, vol. 11, no. 6, pp. 503-11 . https://doi.org/10.1016/S1474-4422(12)70092-3
The lancet neurology
Lancet Neurology, 11, 503-11
Easton, J D, Lopes, R D, Bahit, M C, Wojdyla, D M, Granger, C B, Wallentin, L, Alings, M, Goto, S, Lewis, B S, Rosenqvist, M, Hanna, M, Mohan, P, Alexander, J H, Diener, H-C & ARISTOTLE Committees and Investigators 2012, ' Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack : a subgroup analysis of the ARISTOTLE trial ', Lancet Neurology Network, vol. 11, no. 6, pp. 503-11 . https://doi.org/10.1016/S1474-4422(12)70092-3
Item does not contain fulltext BACKGROUND: In the ARISTOTLE trial, the rate of stroke or systemic embolism was reduced by apixaban compared with warfarin in patients with atrial fibrillation (AF). Patients with AF and previous stroke or transient isc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cc6d53356adaae7968336ba84f3b86f
https://hdl.handle.net/2066/109625
https://hdl.handle.net/2066/109625
Autor:
Gilles De Keulenaer, Ines Monte, Zuzana Motovska, Jaromir Hradec, Roman Leischik, Patrick Jourdain, Hans Prozesky, Michel GALINIER, Wilson Colucci, John Mcmurray, Luc Hittinger, Kurt Boman, MICHELE SENNI, Vyacheslav Yurievich Mareev, Andriy Bazylevych
Publikováno v:
New England Journal of Medicine, 364(1), 11-21. MASSACHUSETTS MEDICAL SOC
A B S T R AC T BACKGROUND Mineralocorticoid antagonists improve survival among patients with chronic, se- vere systolic heart failure and heart failure after myocardial infarction. We evalu- ated the effects of eplerenone in patients with chronic sys
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d95df710df01a58043ced0ddfa49f506
https://research.rug.nl/en/publications/3624d3b6-5bbc-4402-a2d1-5d0832033ef1
https://research.rug.nl/en/publications/3624d3b6-5bbc-4402-a2d1-5d0832033ef1
Autor:
Mario Talajic, Keith Fox, Julián Pérez-Villacastín, Salim Yusuf, Graeme Hankey, Fabio Turazza, WILLIAM HEDDLE, Philippe Gabriel STEG, Fernando Lanas, Harald Jorstad, Vyacheslav Yurievich Mareev, Sergey Golitsyn, Theodore Wein
Publikováno v:
Yusuf, S, Healey, J S, Pogue, J, Chrolavicius, S, Flather, M, Hart, R G, Hohnloser, S H, Joyner, C D, Pfeffer, M A, Connolly, S J, ACTIVE I Investigators & Husted, S 2011, ' Irbesartan in patients with atrial fibrillation ', Briefings from the New England Journal of Medicine, vol. 364, no. 10, pp. 928-38 . https://doi.org/10.1056/NEJMoa1008816
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
BACKGROUND: The risk of cardiovascular events among patients with atrial fibrillation is high. We evaluated whether irbesartan, an angiotensin-receptor blocker, would reduce this risk. METHODS: We randomly assigned patients with a history of risk fac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1c667ad79ebdcf467cd696a2590f40f
https://pure.au.dk/portal/da/publications/irbesartan-in-patients-with-atrial-fibrillation(7aded4eb-30ad-4835-84d9-0d404c8f6288).html
https://pure.au.dk/portal/da/publications/irbesartan-in-patients-with-atrial-fibrillation(7aded4eb-30ad-4835-84d9-0d404c8f6288).html
Autor:
Gad Cotter, Prithwish Banerjee, Catalina Arsenescu Georgescu, Michel GALINIER, Vladimir Zadionchenko, Vyacheslav Yurievich Mareev, Biykem Bozkurt, Piotr Ponikowski, Richard Isnard, Dmitry Zateyshchikov, Marco Metra
Publikováno v:
Journal of Cardiac Failure, 16(1), 25-35. Churchill Livingstone Inc Medical Publishers
Current treatment for acute decompensated heart failure (ADHF) is associated with incomplete resolution of symptoms and signs, recurrent symptoms of heart failure in-hospital and after discharge and high mortality. Studies have consistently demonstra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ba90e3cfe0014488abd76e9d790dc7a
https://cris.maastrichtuniversity.nl/en/publications/6f4c94b7-8011-4de3-9028-70c091d43b76
https://cris.maastrichtuniversity.nl/en/publications/6f4c94b7-8011-4de3-9028-70c091d43b76
Autor:
Lars Kober, Paulo Bettencourt, Oleksii Korzh, Sotir Marchev, Elena Pavlyukova, Frieder Braunschweig, Olga Moiseeva, Oleg Narusov, Oleh Kraidashenko, Catalina Arsenescu Georgescu, Gerald Maurer, Michel GALINIER, Sergey Nedogoda, Ulf Näslund, Dario C Sobral Filho, Vyacheslav Yurievich Mareev, Piotr Ponikowski, Andriy Bazylevych, Niall Mahon, Vojtech Melenovsky, Jan Zbigniew Peruga, Laurence Howes
Publikováno v:
Swedberg, K, Komajda, M, Böhm, M, Borer, J S, Ford, I, Dubost-Brama, A, Lerebours, G, Tavazzi, L, SHIFT Investigators & Gøtzsche, O 2010, ' Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study ', Lancet, vol. 376, no. 9744, pp. 875-85 . https://doi.org/10.1016/S0140-6736(10)61198-1
Udgivelsesdato: 2010-Sep-11 BACKGROUND: Chronic heart failure is associated with high mortality and morbidity. Raised resting heart rate is a risk factor for adverse outcomes. We aimed to assess the effect of heart-rate reduction by the selective sin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea2074c9e4b1a804f7c371a9dc2aeb4a
Autor:
Lars Kober, Massimo Volpe, Jaromir Hradec, Thomas Muenzel, Chang-seng Liang, Vincent Maher, Dulce Brito, John Mcmurray, Kurt Boman, Vyacheslav Yurievich Mareev, Michael Zile, Piotr Ponikowski, Thierry Gillebert
Approximately 50% of patients with heart failure have a left ventricular ejection fraction of at least 45%, but no therapies have been shown to improve the outcome of these patients. Therefore, we studied the effects of irbesartan in patients with th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fac787fb365ad3fa0c8c7ee58a60ee7
Autor:
Aleksandr Svistov, Andrzej Rynkiewicz, Ján Kmec, Lars Kober, Perepech Nikita, Gordon Murray, Oleksii Korzh, Jacek Kubica, Joao Freitas, Jaromir Hradec, Eduardo Perna, Elena Golukhova, Jan Cornel, Antonis Manolis, Olga Moiseeva, Jean-Claude Barthelemy, Christopher Weir, Marianna Janion, Crina Julieta Sinescu, Catalina Arsenescu Georgescu, Michel GALINIER, Sergey Yakushin, Nestor Seredyuk, Philippe Gabriel STEG, Margus Viigimaa, Vladimir Zadionchenko, Ben Freedman, Daniel Pella, Felix Perez-Villa, Sergey Nedogoda, Roberto Ferrari, Yuri Lopatin, Vyacheslav Yurievich Mareev, Thomas Marwick, Yuriy Mostovoy, Viktor Tashchuk, Naida Bulaeva, Piotr Ponikowski, Oleg Zharinov, Andriy Bazylevych, Evgeny Zhilyaev, James Cameron, Andrejs Erglis, Tetyana KHOMAZYUK, Dmitry Zateyshchikov, John Atherton, Yury Vasyuk, Giedrius Varoneckas, David Kaye, Jan F Vojacek, Iurii Rudyk, DİLEK URAL, Sergiy Kolomiets
Publikováno v:
Lancet, 372(9641), 807-816. Elsevier Limited
Summary Background Ivabradine specifically inhibits the I f current in the sinoatrial node to lower heart rate, without affecting other aspects of cardiac function. We aimed to test whether lowering the heart rate with ivabradine reduces cardiovascul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a8d0c627d3c094339baa9c43a712dd7
Autor:
Attila Frigy, Gregor Poglajen, Maria Trukshina, Cristian Podoleanu, Aly Saad, RAQUEL DEL VALLE FERNANDEZ, Lino Goncalves, Michal Marchel, Alexandros PAtrianakos, Vyacheslav Yurievich Mareev, Piotr Ponikowski, Christodoulos Stefanadis, Stefan Naydenov, Manuel Francisco Jiménez Navarro
Publikováno v:
European heart journal
Aims The objective of the EuroHeart Failure Survey II (EHFS II) was to assess patient characteristics, aetiology, treatment, and outcome of acute heart failure (AHF) in Europe in relation to the guidelines on the diagnosis and treatment of AHF publis
Autor:
Vyacheslav Yurievich Mareev
Publikováno v:
Scopus-Elsevier
Europe PubMed Central
Europe PubMed Central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::663a0d53b10e7a02fd14dc34cae20b2c
http://www.scopus.com/inward/record.url?eid=2-s2.0-0346042903&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-0346042903&partnerID=MN8TOARS